Katherine Giannamore
    • Labeling & Claims
    • FDA Label Reviews
    • Label & Marketing Reviews
    • Ingredient Reviews
    • Supplement Facts Panels
    • Outer Packaging Requirements
    • Website Reviews
    • Nutrient Content Claims
    • Organic & Natural Claims
    • Structure/Function Claims
    • Disease Claims
    • Health Claims
    • Food, Supplements & Devices
    • FDA Food Services
    • Dietary Supplement Services
    • 30-Day Notification (NDI)
    • 510(k) / Premarket Clearance
    • Premarket Approval (PMA)
    • Imports, Enforcement & General Counsel
    • FDA Imports
    • Warning Letter Responses
    • FDA Consultant Services
  • About
  • Food & Drug Blog
  • Contact
(866) 785-0873 Schedule a Consultation

Category: FDA

Cosmetic Products and the FDA

color additives, Cosmetics, Disease Claims, FDA, imports, LabelingFDA

FDA Regulation of Cosmetics Products Importers introducing cosmetic products into the United States must be mindful of FDA regulations, which can present a barrier to market entry if the appropriate steps are not taken to ensure compliance. The U.S. Food …

Read More

FDA Imports: Tradeoff — Less Vigilance for More Diligence

FDA

The U.S. Food and Drug Administration (FDA) has found its ability to inspect and re-inspect all of the entities involved in food importing in a slow decline, resulting in delays for those dealing in FDA imports.  Troubled by its inability …

Read More

District Court sides with Industry on Dietary Supplement Substantiation

Dietary Supplements, Disease Claims, Drugs, Enforcement, FDA, Structure-Function Claims, SubstantiationFDA, FTC

A U.S. District judge New Jersey has ruled in United States v. Bayer Corporation that Bayer will not be held in contempt for alleged violations of a 2007 consent decree regarding the marketing of its Phillip’s Colon Health (PCH) product. …

Read More

FDA Clears Device via De Novo Process

510(k), CDRH, FDA, Medical DevicesFDA

On December 8, 2015, the U.S. Food & Drug Administration (“FDA”) cleared for marketing in the United States a cooling cap to reduce hair loss in breast cancer patients undergoing chemotherapy.  Marketed under the name the DigniCap® Cooling System, the …

Read More

FDA “Natural” Food Labeling

Beverages, Dietary Supplements, FDA, Food, Labeling, RulemakingFDA

On November 12, the U.S. Food & Drug Administration (“FDA”) announced that it is soliciting public comments on how the Agency should define the term “natural” and regulate its use in food labeling. The FDA has engaged the public’s input …

Read More

What’s in a Name? Everything, for “Standard” FDA Food Labeling

FDA

FDA Particular words mean everything to the U.S. Food and Drug Administration (FDA).  It takes great pains and uses specific words to proclaim its position, and clarify what it names something, especially when it comes to setting a standard.  Most …

Read More

FDA Bans Trans Fats

Beverages, FDA, Food, imports, Labeling, Nutrition Facts, RulemakingFDA

FDA Issues Final Determination Concerning Partially Hydrogenated Oils The U.S. Food and Drug Administration (FDA) has long reacted to the public concern over trans fatty acids (also known as TFA or trans fats) found in foods as a part of …

Read More

FDA Issues Tobacco Warning Letters for Tobacco Retailer Inspection Violations

Enforcement, FDA, Inspection Violations, Tobacco Control Act, Tobacco Retailer Inspections, Tobacco Warning Letter, Warning LettersFDA

The U.S. Food and Drug Administration (FDA) has been ramping up their enforcement efforts against tobacco retailers in recent months for compliance with the Federal Food, Drug, and Cosmetic Act (FD&C Act) by issuing countless tobacco warning letters in connection …

Read More

Potential Changes to FDA Regulation of Homeopathic Drugs

Drugs, FDA, Homeopathic, Labeling, OTC DrugsFDA

On April 20, 2015 the Food and Drug Administration (FDA) heard testimony regarding homeopathic drugs and the Agency’s role in the regulation thereof. These two-day long hearings come after the FDA received over 1,500 public comments about the possibility of …

Read More

US Marshals Seize Topical Products Deemed Drugs by FDA

Disease Claims, Drugs, Enforcement, FDAFDA

On April 16, 2015, U.S. Marshals seized what the U.S. Food & Drug Administration (“FDA”) classified as unapproved prescription drugs from Stratus Pharmaceuticals, Inc. of Miami, Florida. Stratus purchased these unapproved prescription drugs, worth over $1.5 million, from Sonar Products, …

Read More

Posts pagination

< Page 1 Page 2 Page 3 Page 4 … Page 13 >

    Katherine L. Giannamore
    Rated by Super Lawyers


    loading ...
    Shehadeh Giannamore, PLLC

    Toll-free: (866) 785-0873
    Direct: (305) 507-9843
    Email: contact@giannamore-law.com

    Reachable seven days a week · Response within 24 hours

    Practice Areas

    • Food & Beverage
    • Dietary Supplements
    • Cosmetics & Labeling
    • Medical Devices
    • Drugs & OTC
    • Enforcement & Import Defense

    Popular Services

    • FDA Label Reviews
    • Ingredient Reviews
    • FDA Imports
    • Warning Letter Responses
    • 30-Day NDI Notification

    Firm

    • About
    • Food & Drug Blog
    • Contact
    • Google Reviews

    Information shared on this website and blog is for informational purposes only and may not provide the most up-to-date legal and regulatory information, as we do not provide updates to individual articles after publication. Any commentary or legal analysis herein is for general informational purposes and not to be relied upon for individual legal advice and does not establish an attorney-client relationship.

    © 2026 Shehadeh Giannamore, PLLC. All rights reserved.